These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4128043)

  • 1. Letter: Epstein-Barr virus and infectious mononucleosis.
    Royston I
    Lancet; 1973 Nov; 2(7838):1152. PubMed ID: 4128043
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    Bibl Haematol; 1975 Oct; (43):278-80. PubMed ID: 183684
    [No Abstract]   [Full Text] [Related]  

  • 4. Infectious mononucleosis and Epstein-Barr virus in Japan. II. Cellular aspects.
    Takiuchi Y; Tatsumi E; Nasu K; Shirakawa S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):864-71. PubMed ID: 6277135
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression of cell-mediated immunity during acute infectious mononucleosis.
    Mangi RJ; Niederman JC; Kelleher JE; Dwyer JM; Evans AS; Kantor FS
    N Engl J Med; 1974 Nov; 291(22):1149-53. PubMed ID: 4370990
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB
    Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of infectious mononucleosis.
    McCue JD
    Hosp Pract (Off Ed); 1982 Oct; 17(10):34, 34A-F, 34J-M. PubMed ID: 6288544
    [No Abstract]   [Full Text] [Related]  

  • 8. Infectious mononucleosis: model for self-limiting lymphoproliferation.
    Carter RL
    Lancet; 1975 Apr; 1(7911):846-9. PubMed ID: 48066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus genome in infectious mononucleosis.
    Pagano JS; Huang CH; Huang YT
    Nature; 1976 Oct; 263(5580):787-9. PubMed ID: 186715
    [No Abstract]   [Full Text] [Related]  

  • 11. A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis.
    Smith RS; Rhodes G; Vaughan JH; Horwitz CA; Geltosky JE; Whalley AS
    J Infect Dis; 1986 Nov; 154(5):885-9. PubMed ID: 3021871
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.
    Miller G; Niederman JC; Andrews LL
    N Engl J Med; 1973 Feb; 288(5):229-32. PubMed ID: 4345064
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological cell surface markers in infectious mononucleosis (author's transl)].
    Ritter J; Oehme J
    Klin Wochenschr; 1976 Jul; 54(13):647-8. PubMed ID: 181637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus.
    Rickinson A
    Virus Res; 2002 Jan; 82(1-2):109-13. PubMed ID: 11885937
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis.
    Britton S; Andersson-Anvret M; Gergely P; Henle W; Jondal M; Klein G; Sandstedt B; Svedmyr E
    N Engl J Med; 1978 Jan; 298(2):89-92. PubMed ID: 201839
    [No Abstract]   [Full Text] [Related]  

  • 19. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM
    Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.